Avoro Capital

Avoro Capital is a global life sciences investment firm headquartered in New York. Its mandate spans both sides of the biotechnology capital structure: publicly traded biotechnology companies and late-stage private therapeutic companies holding what it describes as strategic assets. The firm was formerly known as venBio Select Advisor.

The investment approach combines detailed analysis of complex situations with active risk management. Portfolio construction is governed by explicit attention to hedging, position sizing, liquidity and macroeconomic risk, and the firm states that it seeks unique or mispriced opportunities rather than broadly benchmarked exposure. Sector focus is confined to life sciences, with an emphasis on therapeutic companies whose scientific work addresses unmet medical needs.

Alongside capital, Avoro Capital provides what it terms intellectual support to portfolio companies across the investment lifecycle - a model that implies sustained engagement with scientific and medical due diligence rather than passive share ownership. Technical domains covered by the firm include biotechnology, therapeutics, scientific and medical due diligence, and investment risk management. Its geographic presence is described as global.